• Contact Us
Wednesday, January 21, 2026
Health Business
Advertisement
  • Home
  • News
    NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

    NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

    Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

    Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

    PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    Hazardous Waste Landfill in Wajir Remains Active Despite Court Oder

    Hazardous Waste Landfill in Wajir Remains Active Despite Court Oder

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

    NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

    Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

    Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

    PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    Hazardous Waste Landfill in Wajir Remains Active Despite Court Oder

    Hazardous Waste Landfill in Wajir Remains Active Despite Court Oder

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Emerging sex disease MG ‘could become next superbug’

by Health Business
July 19, 2018
in News
0
Emerging sex disease MG ‘could become next superbug’
Share This:

A little known sexually transmitted infection could become the next superbug unless people become more vigilant, experts are warning.

Mycoplasma genitalium(MG) often has no symptoms but can cause pelvic inflammatory disease, which can leave some women infertile.

MG can be missed – and if it is not treated correctly, it can develop resistance to antibiotics.

TheBritish Association of Sexual Health and HIVis launching new advice.

Its draft guidelines detail how best to spot and treat MG.

What is MG?

Mycoplasma genitalium isa bacterium that can cause inflammation of the urethra in men, causing discharge from the penis and making it painful to urinate.

In women, it can cause inflammation of the reproductive organs (womb and fallopian tubes) too, causing pain and possibly a fever and some bleeding.

You can get it by having unprotected sex with someone who has it. Condoms can prevent this spread.

It was first identified in the UK in the 1980s and is thought to affect 1-2% of the general population.

MG does not always cause symptoms and will not always need treatment, but it can be missed or mistaken for a different sexually transmitted infection, such as Chlamydia.

The BASHH says this is concerning.

Tests for MG have recently been developed but are not available in all clinics yet although doctors can send samples to Public Health England’s laboratory to get a diagnostic result.

It can be treated with antibiotics – but the infection is developing resistance to some of these drugs.


‘I tested positive for MG’

John – not his real name – contacted the BBC to tell of his experience of having the infection.

“I was diagnosed with MG last year after meeting my new partner.

“We both sensibly got tested and declared clean at the start of the relationship but GUM [genitourinary medicine] clinics don’t test for MG, unless you have symptoms.

“So about a month into the relationship I developed the male symptoms – a sharp burning pain while urinating and a pus-like dishcharge from my urethra – but I had no idea what was wrong.

“After a few weeks I tested positive, while my partner was negative, which didn’t make sense. She then got tested again and was positive.

“We were put on antibiotics for two weeks but had no sexual contact for five, to make sure we were clean. After further tests we both tested negative but I still had some small amount of leakage which I was told would go away. It eventually cleared.

“Then out of the blue I got a UTI and symptoms were exactly like MG.

“I am now certain it has returned and I am awaiting further test results.

“The GUM clinic refused to retest my partner as she hasn’t shown any symptoms.

“I think clinics should test for MG as part of their sexual health screening process, as this would have been picked up at the start for me.”


‘Pack condoms’

Eradication rates of MG following treatment with one family of antibiotics, called macrolides, are decreasing globally. Macrolide resistance in the UK is estimated at about 40%, say the guidelines.

One particular macrolide antibiotic, azithromycin, still works in most cases however.

Dr Peter Greenhouse, a sexual consultant in Bristol and BASHH member, urged people to take precautions.

“It’s about time the public learned aboutMycoplasma genitalium,” he said.

“It’s yet another good reason to pack the condoms for the summer holidays – and actually use them.”

‘Out of control’

Paddy Horner, who co-wrote the guidelines, said: “These new guidelines have been developed, because we can’t afford to continue with the approach we have followed for the past 15 years as this will undoubtedly lead to a public health emergency with the emergence of MG as a superbug.

“Our guidelines recommend that patients with symptoms are correctly diagnosed using an accurate MG test, treated correctly then followed up to make sure they are cured.

“Resources are urgently needed to ensure that diagnostic and antimicrobial resistance testing is available for women with the condition who are at high risk of infertility.

“We are asking the government directly to make this funding available to prevent a public health emergency waiting to happen and which is already spiralling out of control.”

Public Health England says testing is available to diagnose MG and any signs of drug resistance, if necessary.

Dr Helen Fifer, consultant microbiologist at Public Health England, welcomed the guidelines, adding: “If you have symptoms of an STI, we recommend you get tested at your local sexual health clinic.

“Everyone can protect themselves from STIs by consistently and correctly using condoms with new and casual partners. -BBC

Share This:
Previous Post

Rural women have sex early, study finds

Next Post

Thai cave rescue: The Australian diving doctor who stayed with the boys

Related Posts

NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future
News

NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

January 19, 2026
Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge
News

Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

January 15, 2026
PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month
News

PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

January 13, 2026
Next Post
Thai cave rescue: The Australian diving doctor who stayed with the boys

Thai cave rescue: The Australian diving doctor who stayed with the boys

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

    0 shares
    Share 0 Tweet 0
  • Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

    0 shares
    Share 0 Tweet 0
  • NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

NEPHAK Challenges Parliament to Seize Control of Kenya’s HIV Future

January 19, 2026
Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

Oxford Licenses Rift Valley Fever Vaccine to Serum Institute Amid West Africa Surge

January 15, 2026
PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

PS Muthoni Calls for Increased Cervical Cancer Screening during January Awareness Month

January 13, 2026

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.